Product Image

Contributor Information

  • Name Medical-Industrial Translational Research Center
  • Institute Fukushima Medical University

Tool Details

  • Tool name: MCF10A-NRASm-3 cell line
  • Alternate names: 06M00064
  • Clone: NRAS_type-03
  • Tool type: Cell Lines
  • Tool sub-type: Continuous
  • Parental cell line: MCF10A, a non-tumorigenic cell line from human mammarygland epithelium
  • Organism: Human
  • Tissue: Mammarygland epithelium
  • Cancer type: Non-tumorigenic
  • Morphology: Epithelial
  • Growth properties: Adherent
  • Model: Mutant
  • Model description: Type: Type-03; Type mutation: G12D; CDS mutation: c.35G>A; AA mutation: p.G12D; COSMIC Mutation ID: COSM564
  • Application: Functional analysis of mutated genes, Drug screening
  • Description: Non-tumorigenic immortalized breast epithelial cell stably overexpressing mutant cancer-related genes. NRAS (neuroblastoma RAS viral (v-ras) oncogene homolog). A cancer gene that belongs to the low-molecule GTPase called the RAS family. It is thought to play an essential role in the MAPK signaling pathway like KRAS, a representative of the RAS family. While the mutation of KRAS is frequently found in bowel cancer (approx. 30%), the frequency of NRAS's mutation in bowel cancer is approximately 4% and it is known to be found more often in skin tumors (approx. 19%) and blood tumors such as leukemia and myelodysplastic syndrome (approx. 12%). Mutation of Q61 and G12 are known as somatic cell mutations that are often found in cancer.
  • Research area: Cancer; Cell biology

  • For Research Use Only

Target Details

  • Target: Neuroblastoma RAS viral oncogene homolog [NRAS]
  • Target background: Gene ID: 4893; References: DNA (mRNA): NM_002524.4; Protein: NP_002515.1

Application Details

  • Application: Functional analysis of mutated genes, Drug screening

Handling

  • Format: Frozen
  • Growth medium: DMEM/Ham's F-12 supplemented with 5% heat-inactivated horse serum, 10 Â?g/ml insulin (human, recombinant), 5 Â?M forskolin, 0.5 Â?g/ml hydrocortisone, 20 ng/ml EGF (human, recombinant), 100 U/ml penicillin, and 100 Â?g/ml streptomycin
  • Temperature: 37?C
  • Atmosphere: Humidified incubator with 5% CO2
  • Storage medium: CELLBANKER 2 (Zenogen pharma)
  • Storage conditions: Liquid Nitrogen
  • Shipping conditions: Dry ice
  • Characterisation tests: Comprehensive gene expression analysis; Identification of cell proliferation and cellular form; Drug sensitivity tests
  • Initial handling information: Thaw the vial at 37 °C in a water bath?then seed cells into a T75 flask. Culture in a humidified Incubator at 37 ? with 5% CO2 in air. Culture medium should be changed every 2 to 3 days.
  • Cultured in antibiotics?: 100 U/ml Penicillin, and 100 Â?g/ml Streptomycin
  • Mycoplasma free: Yes
  • Biosafety level: 1

Documentation